Viewing Study NCT01253551


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-30 @ 2:43 PM
Study NCT ID: NCT01253551
Status: COMPLETED
Last Update Posted: 2012-10-16
First Post: 2010-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Sponsor: Tibotec BVBA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module